- What does LFSC invest in?
- The F/M Emerald Life Sciences Innovation ETF (LFSC) strategically invests in pioneering life science enterprises. Its core objective is to identify companies that are well-positioned for substantial long-term growth and the creation of significant value. As an actively managed fund, LFSC benefits from a highly specialized and experienced team dedicated to conducting in-depth research into complex life sciences firms. The fund primarily targets U.S. equity securities, selecting those that demonstrate strong growth potential. Specific criteria for inclusion involve a company's leadership in technological advancement, its capacity for market disruption, or its innovative application of artificial intelligence. The expansive field of life sciences, as defined by the fund, encompasses various sectors including biotechnology, pharmaceuticals, medical diagnostics and devices, healthcare services and technologies, and synthetic biology. Stock selection is guided by a rigorous and extensive 10-step research framework. This meticulous process incorporates: Reviews of publicly accessible and external third-party information. Comprehensive peer reviews. Development of detailed financial and valuation models. In-house research and surveys. Direct engagement and interviews with company management, industry and medical experts, and supply chain representatives. Robust internal collaboration among the investment team. While its primary focus is on domestic equities, the fund retains the flexibility to allocate up to 20% of its capital to foreign companies, provided they are listed and traded on a U.S. exchange.
- What is the expense ratio of LFSC?
- F/M Emerald Life Sciences Innovation ETF (LFSC) charges an expense ratio of 0.79%. This is the annual fee deducted from fund assets to cover management and operations.
- How big is LFSC?
- F/M Emerald Life Sciences Innovation ETF (LFSC) manages $127.0M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.
- Is LFSC actively managed or an index fund?
- LFSC is actively managed — the manager selects holdings rather than tracking an index. Active funds typically charge higher expense ratios than index funds (LFSC's is 0.79%) in exchange for the discretion to over- or under-weight positions.
- When was LFSC launched?
- F/M Emerald Life Sciences Innovation ETF (LFSC) launched in October 2024 and is managed by Emerald.
- How has LFSC performed?
- LFSC's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.
